Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ureteroileocolic sigmoidostomy]

K Kashiwai, N Yatake, Y Mori

    Shujutsu. Operation
    |August 1, 1971
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Eight-year survival with metastatic oesophageal carcinoma: a case report and review of the literature.

    South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie·2026
    Same author

    Artifact reduction in low and ultra-low dose chest computed tomography for patients with pacemaker: A phantom study.

    Radiography (London, England : 1995)·2024
    Same author

    The effect of nano hydroxyapatite coating implant surfaces on gene expression and osseointegration.

    Medicina oral, patologia oral y cirugia bucal·2023
    Same author

    Visualization of Nigrosome 1 from the Viewpoint of Anatomic Structure.

    AJNR. American journal of neuroradiology·2019
    Same author

    Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.

    Science (New York, N.Y.)·2019
    Same author

    Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial.

    Breast cancer (Tokyo, Japan)·2018